Chargement en cours...
Type‐2 airway inflammation in mild asthma patients with high blood eosinophils and high fractional exhaled nitric oxide
Type‐2 (T2) inflammation is a characteristic feature of asthma. Biological therapies have been developed to target T2‐inflammation in asthma. IL‐13 is a key component of T2‐inflammation in asthma, driving mucus hypersecretion, IgE‐induction, and smooth muscle contraction. Early phase clinical trials...
Enregistré dans:
| Publié dans: | Clin Transl Sci |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8301554/ https://ncbi.nlm.nih.gov/pubmed/34106513 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.13078 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|